A detailed history of Bank Of America Corp transactions in Sonoma Pharmaceuticals, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 172 shares of SNOA stock, worth $481. This represents 0.0% of its overall portfolio holdings.

Number of Shares
172
Previous 44 290.91%
Holding current value
$481
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$0.14 - $0.26 $17 - $33
128 Added 290.91%
172 $0
Q3 2022

Nov 14, 2022

SELL
$2.18 - $43.4 $16,092 - $320,378
-7,382 Reduced 99.41%
44 $0
Q2 2022

Aug 12, 2022

BUY
$2.65 - $4.12 $19,562 - $30,413
7,382 Added 16777.27%
7,426 $21,000
Q3 2021

Nov 15, 2021

SELL
$5.23 - $8.89 $104 - $177
-20 Reduced 31.25%
44 $0
Q2 2021

Sep 13, 2021

BUY
$7.12 - $9.15 $455 - $585
64 New
64 $0

Others Institutions Holding SNOA

About Sonoma Pharmaceuticals, Inc.


  • Ticker SNOA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 3,100,940
  • Market Cap $8.68M
  • Description
  • Sonoma Pharmaceuticals, Inc., develops and produces stabilized hypochlorous acid (HOCl) products for wound care, animal health care, eye care, oral care, and dermatological conditions in the United States, Latin America, Europe, and internationally. The company offers Epicyn, an antimicrobial facial cleanser; Levicyn, an HOCl based prescription ...
More about SNOA
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.